Focus on Pharma:Inside the Pfizer-Wyeth Deal

Pfizer,the largest U.S. drugmaker,is acquiring rival Wyeth.Pfizer CEO Jeff Kindler says they've spent the last few years really strengthening Pfizer,and now they're in the position to do a really transformative transaction.It is to be financed through a combination of cash,debt and stock.This deal meaningfully addresses challenges like the patent expiration of Pfizer's blockbuster cholesterol drug Lipitor.The deal is for 68 billion dollars in cash and stock.Mr.Kindler believes Wyeth is a great fit for Pfizer.